UMIN-CTR History

Name:  UMIN ID:


Unique ID issued by UMIN UMIN000013607
Receipt number R000015893
Scientific Title Observational study of Pertuzumab,Trastuzumab and taxane combination therapy for patient with pretreated HER2-positive advanced or recurrent breast cancer.
Date of disclosure of the study information 2014/04/02
Last modified on 2017/04/05 08:44:47

No. Disposal Last modified on Item of update
1 Insert 2014/04/02 11:44:45
2 Update 2017/04/05 08:43:57 Name of primary person or sponsor
Organization
3 Update 2017/04/05 08:44:47 Recruitment status